Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Mayo Clinic
Fate Therapeutics
Genocea Biosciences, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins